ArticleBMC pharmacology & toxicology2026
Biomonitoring-informed neonicotinoid mixture exposure reveals modest cytotoxicity and cell-type-specific molecular responses in human cell lines.
Article in BMC pharmacology & toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Integrative analysis of cadmium exposure and osteoarthritis: from population evidence to molecular mechanisms.Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundNeonicotinoids (NEOs) are widely detected in environmental matrices and in humans, raising concerns about potential health risks. However, most toxicological studies have focused on single compounds and/or concentrations far exceeding biomonitoring-relevant exposure ranges.
methodsWe developed a UPLC-MS/MS method to quantify eight NEOs and five metabolites in human urine. Using environmental monitoring and urinary biomonitoring data from Hainan Island, China, we constructed exposure-informed NEO mixture profiles based on surface water, tap water, and urinary concentrations, and evaluated their cytotoxicity in four human cell lines (A2780, HEK293T, HeLa, and HepG2). Toxicity was assessed via cell viability, oxidative stress, DNA fragmentation, and integrated multi-omics analyses, with the urinary-biomonitoring-informed mixture evaluated across four cell lines and the surface/tap-water mixtures assessed as an initial transcriptomic screen in HEK293T cells.
resultsEnvironmentally relevant mixtures (surface/tap water) elicited only limited transcriptomic changes (≤ 0.34% of genes). In contrast, biomonitoring-informed mixtures (≈ 0.1 µM ΣNEOs) induced modest but detectable dose-dependent cytotoxicity, with viability reductions of 3-8%, modest oxidative stress, and limited increases in DNA fragmentation, with effects distinct from individual compounds at matched concentrations. Transcriptomic analysis revealed cell-type-specific responses converging on three core modules: innate immune-like inflammatory signaling, ER stress/unfolded protein response, and metabolic reprogramming. Metabolomic profiling identified two dominant perturbation patterns-arginine/nitrogen-centered rewiring (A2780 and HEK293T) versus membrane lipid remodeling (HeLa and HepG2).
conclusionsBiomonitoring-informed NEO/metabolite mixtures elicited measurable, cell-specific molecular perturbations within biomonitoring-relevant concentration ranges, engaging coordinated stress and adaptation programs. These findings support the incorporation of mixture composition and biomonitoring-relevant concentration ranges into future toxicological evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.